PKI-166
CAS: 187724-61-4
Rif. 3D-MHA72461
| 25mg | Prezzo su richiesta | ||
| 50mg | Prezzo su richiesta | ||
| 100mg | Prezzo su richiesta |
Informazioni sul prodotto
PKI-166 is a mitochondria-targeted prodrug that has been shown to be cytotoxic in vitro and in vivo. It binds to the mitochondrial membrane and causes depolarization, which leads to apoptosis. PKI-166 has also been shown to inhibit tumor growth in a rat model of subcutaneous tumors. The drug is cell type specific and does not affect normal cells such as fetal bovine or mouse embryonic fibroblasts. PKI-166 is activated by dna binding activity and can bind to DNA as well as proteins such as epidermal growth factor (EGF) and tetrazolium dye. PKI-166 has pharmacokinetic properties that are different from other drugs in its class, which include a long half-life and low clearance rate. The drug also inhibits the proliferation of carcinoma cell lines with high epidermal growth factor receptor expression levels, but not with low EGF receptor expression levels.
Proprietà chimiche
Richiesta tecnica su: 3D-MHA72461 PKI-166
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.
